Tuesday, January 27, 2015 Last update: 4:03 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Organovo Holdings, Inc.

News articles for Organovo Holdings, Inc.:

Monday, December 15, 2014

Tuesday, December 9, 2014

Monday, December 8, 2014

  • Organovo Appoints Dr. Kirk Malloy to Board of Directors
    SAN DIEGO, Dec. 8, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today Kirk D. Malloy, Ph.D. has been appointed to the Company's Board of Directors. Dr. Malloy has held management and executive ... read more

Wednesday, December 3, 2014

Thursday, November 20, 2014

Tuesday, November 18, 2014

  • Organovo Announces Commercial Release of the exVive3D(TM) Human Liver Tissue
    SAN DIEGO, Nov. 18, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today announced the full commercial release of the exVive3D(TM) Human Liver Tissue for preclinical drug discovery testing. Initially, clients will be ... read more

Monday, November 10, 2014

  • Organovo Holdings, Inc. Reports Second Quarter Results
    SAN DIEGO, Nov. 10, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering pioneering 3D bioprinting technology, has reported its second quarter, fiscal 2015, results. Keith Murphy, chairman and chief executive officer of Organovo, commented on the results: "Last ... read more

Tuesday, September 30, 2014

Monday, September 15, 2014

Tuesday, September 9, 2014

  • Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com September 11
    Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual RetailInvestorConferences.com NEW YORK, Sept. 9, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO; "Organovo") the San Diego-based regenerative medicine company focused on using its breakthrough NovoGen 3D human tissue printing technology to create tissue on ... read more

Friday, September 5, 2014

  • Organovo to Present at the Morgan Stanley Global Healthcare Conference
    SAN DIEGO, Sept. 5, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has been invited to present at the Morgan Stanley Global Healthcare Conference, which will be held in New York September 8-10, 2014. Organovo's ... read more

Tuesday, August 26, 2014

  • Organovo Named 2015 Technology Pioneer by World Economic Forum
    SAN DIEGO, Aug. 26, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering pioneering 3D bioprinting technology, announced today that it has been recognized as a 2015 Technology Pioneer by the World Economic Forum (WEF). Organovo is ... read more

Tuesday, August 12, 2014

  • Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results
    SAN DIEGO, Aug. 12, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering pioneering 3D bioprinting technology, has reported its first quarter, fiscal 2015, results and provided highlights of its recent activities. During the quarter, Organovo demonstrated, in collaboration with a major pharmaceutical ... read more

Wednesday, August 6, 2014